Inhibition of sulfotransferase SULT2B1 prevents obesity and insulin resistance by regulating energy expenditure and intestinal lipid absorption
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Jingyuan Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Sulfotransferases, Obesity, Insulin Resistance, Energy Metabolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIEHS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Obesity is a major risk factor for multiple metabolic diseases, including type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD). The cholesterol sulfotransferase SULT2B1 is best known for its function in converting cholesterol to cholesterol sulfate. Here, by using the high-fat diet (HFD)-induced obesity model and the genetic obese ob/ob mice, we showed that genetic ablation of Sult2b1 protected mice from developing obesity and related insulin resistance, hepatic steatosis, and adipose tissue inflammation. Loss of Sult2b1 increased energy expenditure without affecting food intake or locomotive activity. The cold exposure test revealed that loss of Sult2b1 promoted thermogenesis in brown adipose tissue, which may have contributed to increased energy expenditure. In vivo reconstitution experiments suggested that the loss of Sult2b1 in extrahepatic tissues might have been responsible for the metabolic benefit. Mechanistically, our in vivo lipid uptake and metabolomic analyses showed that the Sult2b1KO mice exhibited suppression of intestinal dietary lipid absorption and the consequent downregulation of both systemic fatty acid levels and fatty acid metabolism. Our results suggest that targeting SULT2B1 may represent a novel strategy to combat obesity and related metabolic syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Endocrinology and Metabolic Disease, The First Affiliated Hospital, Zhejiang…
- Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsy…
Förderung
- NIGMS NIH HHS
- NIEHS NIH HHS
- NIDDK NIH HHS
- National Institute of Environmental Health Sciences
- NIH National Institute of General Medical Sciences
- National Institutes of Health
- University of Pittsburgh
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Wang, J., Young, G., Zhang, M., Salvatore, S. R., Qin, F. Y., Cai, X., Xu, M., Ke, M., Liu, L., Kim, J. W., Xu, P., Yang, B., Ren, S., Feng, Y., Yang, D., Ma, X., Schopfer, F. J., & Xie, W. (2025). Inhibition of sulfotransferase SULT2B1 prevents obesity and insulin resistance by regulating energy expenditure and intestinal lipid absorption. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110327
Vancouver
Wang J, Young G, Zhang M, Salvatore SR, Qin FY, Cai X, et al. Inhibition of sulfotransferase SULT2B1 prevents obesity and insulin resistance by regulating energy expenditure and intestinal lipid absorption. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110327
BibTeX
@article{Wang2025,
author = {Wang, Jingyuan and Young, Gregory and Zhang, Min and Salvatore, Sonia R and Qin, Fu-Ying and Cai, Xinran and Xu, Meishu and Ke, Mengyun and Liu, Lingyi and Kim, Jong-Won and Xu, Pengfei and Yang, Bin and Ren, Songrong and Feng, Ye and Yang, Da and Ma, Xiaochao and Schopfer, Francisco J and Xie, Wen},
title = {Inhibition of sulfotransferase SULT2B1 prevents obesity and insulin resistance by regulating energy expenditure and intestinal lipid absorption},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110327}
}
EUVIMED